Skip to content

Pilot Trial of Peer Support for Bipolar Disorder

Pilot Trial of Peer Support for Bipolar Disorder

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02404246
Enrollment
88
Registered
2015-03-31
Start date
2005-12-31
Completion date
2009-09-30
Last updated
2017-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder

Keywords

Bipolar, Peers, DBSA

Brief summary

This pilot effectiveness trial will evaluate the feasibility, acceptability, and effectiveness of a structured peer support program based on the Certified Peer Specialist Program of the Depression and Bipolar Support Alliance (DBSA).

Detailed description

Bipolar disorder is a chronic and often disabling illness affecting 1-2% of US adults. Peer support programs are an innovative and promising model to reverse demoralization, activate consumers to seek more effective care, develop consumers' self-management skills, and restore participation in work and other social roles. Peer-led programs can address key barriers to dissemination of effective psychosocial treatment. This pilot effectiveness trial will evaluate the feasibility, acceptability, and effectiveness of a structured peer support program based on the Certified Peer Specialist Program of the Depression and Bipolar Support Alliance (DBSA). Following the philosophy of recovery, the intervention focuses on: * Motivating consumers to develop an expectation of recovery * Encouraging regular self-monitoring of mood symptoms * Training consumers to develop self-management skills for symptom control and problem solving * Activating consumers to be more informed partners in care and more effective self-advocates * Motivating and assisting consumers to reclaim work and other rewarding social roles The investigators will use a rigorous research design to evaluate how structured peer support promotes core values of mental health recovery. Impact of the intervention will be judged across a range of outcomes: * Long-term control of mood disorder symptoms * Optimal participation in work and other rewarding social roles * Consumers' perceptions of autonomy and full participation in the treatment process Findings from this pilot study will inform the development of a full-scale effectiveness trial to include a broader range of participants and health care settings.

Interventions

Sponsors

Kaiser Permanente
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* GHC members aged 18 and over with Bipolar Disorder Type 1 or Type 2 and at least 6 weeks during the past 3 months with a depression or mania/hypomania Psychiatric Status Rating of 3 or greater (indicating significant symptoms at least half of the time). Potential participants will not be excluded because of medical, psychiatric, or substance use comorbidity.

Exclusion criteria

* Children under age 18.

Design outcomes

Primary

MeasureTime frame
Mean differences in depression scores using the Structured Clinical Interview for DSM Disorders (SCID) for current depression and LIFE measure and timeline for depressionup to 9 months
Mania PSR scores using the Structured Clinical Interview for DSM Disorders (SCID) for mania/Hypo-mania and LIFE measure and timeline for maniaup to 9 months
Intervention program effects on consumer's perceptions of care across follow-ups using self-efficacy tool, POPP Empowerment (Well-Being Module) and Health Care Climate questionnaireup to 9 months

Secondary

MeasureTime frame
Mean number of weeks with depression during follow-ups.up to 9 months
Mean number of weeks using mania PSR scores during follow-ups.up to 9 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026